Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4146)
All Articles published online
|
Publishing Process of This Article
|
Oct 21, 2024 (publication date) through Jan 24, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Singh A, Sohal A, Batta A. Recent developments in non-invasive methods for assessing metabolic dysfunction-associated fatty liver disease. World J Gastroenterol 2024; 30(39): 4324-4328 [PMID: 39492822 DOI: 10.3748/wjg.v30.i39.4324] |
|
|
|
| ©2004-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Singh A, Sohal A, Batta A. Recent developments in non-invasive methods for assessing metabolic dysfunction-associated fatty liver disease. World J Gastroenterol 2024; 30(39): 4324-4328 [PMID: 39492822 DOI: 10.3748/wjg.v30.i39.4324] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v30/i39/4324.htm |
| Number | Citing Articles |
| 1 |
Tobias Harm, Anne-Katrin Rohlfing, Jessica Kristin Henes, Nicole Manzat, Michal Droppa, Malte Bongers, Mathias Heikenwaelder, Karin Müller, Meinrad Gawaz, Dominik Rath. Reduced Platelet Aggregation and Plasma Cytokine Levels Mitigate Progressive Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Journal of Inflammation Research 2025; : 11385 doi: 10.2147/JIR.S533707
|
| 2 |
Dae-Jeong Koo, Yun Tae Kim, Sun-Joon Moon, Hyemi Kwon, Se Eun Park, Sang Min Lee, Cheol-Young Park, Won-Young Lee, Sung Rae Cho, Eun-Jung Rhee. Hepatorenal vulnerability flagged by glomerular hyperfiltration in metabolic liver disease: a large health-screening cohort evidence. Diabetology & Metabolic Syndrome 2026; doi: 10.1186/s13098-025-02070-3
|
| 3 |
Chiara Rovera, Alice Del Zoppo, Giovanni Petralli, Diego Moriconi, Chiara Rossi, Mariarosaria Distaso, Maurizia Rossana Brunetto, Ele Ferrannini, Francesco Raggi, Anna Solini. Effect of bempedoic acid on incretin axis and systemic and liver inflammation: a pilot, monocentric study. Nutrition, Metabolism and Cardiovascular Diseases 2026; 36(2): 104373 doi: 10.1016/j.numecd.2025.104373
|
| 4 |
Supatsri Sethasine, Thananda Trakarnvanich, Witchakorn Ruamtawee, Nutachat Treerasoradaj, Paweena Susantitaphong. Association of noninvasive tests of liver fibrosis with chronic kidney disease in MASLD: a systematic review and meta-analysis. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-26752-0
|
| 5 |
Said A. Al-Busafi, Mohammed Eslam. Liver Transplantation in the Era of Metabolic Dysfunction–Associated Fatty Liver Disease: Challenges, Ethical Dilemmas, and Future Directions. Transplantology 2025; 6(4): 35 doi: 10.3390/transplantology6040035
|
| 6 |
Juan Zhou, Min Liu, Jun Qiu, Wenxian Ouyang, Guanghui Zhu, Weijian Chen, Shuangjie Li, Hongmei Zhao. Diagnostic value of non-invasive indices for assessing liver fibrosis in Chinese children with metabolic dysfunction-associated steatotic liver disease. Frontiers in Pediatrics 2026; 13 doi: 10.3389/fped.2025.1694863
|
| 7 |
Zhengjin Wang, Zhangxin Chen, Hanxu Zhuang. Association between urinary albumin-to-creatinine ratio and all-cause and cardiovascular-cause mortality among MASLD: NHANES 2001–2018. Frontiers in Nutrition 2025; 12 doi: 10.3389/fnut.2025.1528732
|